<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01453465</url>
  </required_header>
  <id_info>
    <org_study_id>ABTR12B1</org_study_id>
    <secondary_id>NCI-2011-03468</secondary_id>
    <secondary_id>CDR0000712872</secondary_id>
    <secondary_id>ABTR12B1</secondary_id>
    <secondary_id>COG-ABTR12B1</secondary_id>
    <secondary_id>ABTR12B1</secondary_id>
    <secondary_id>ABTR12B1</secondary_id>
    <nct_id>NCT01453465</nct_id>
  </id_info>
  <brief_title>Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor</brief_title>
  <official_title>Gene Expression (GE) and MicroRNA (MIRNA) Expression Profiles of Malignant Rhabdoid Tumors (MRT) of the Kidney (RTK) and Atypical Teratoid Rhabdoid Tumor (ATRT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Oncology Group</source>
  <brief_summary>
    <textblock>
      This research trial studies biomarkers in samples from patients with rhabdoid tumor of the
      kidney and atypical teratoid rhabdoid tumor. Studying biomarkers of tissue samples from
      patients with cancer in the laboratory may help doctors learn more about changes the occur in
      DNA and identify biomarkers related to cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      I. To determine if there are molecular differences between rhabdoid tumor of the kidney (RTK)
      and the atypical teratoid rhabdoid tumor (ATRT).

      OUTLINE:

      Archived tumor tissue samples are analyzed for gene expression profile and microRNA profile.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <start_date type="Actual">November 1, 2011</start_date>
  <primary_completion_date type="Actual">December 1, 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Molecular differences between RTK and the ATRT</measure>
    <time_frame>Up to 3 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Childhood Atypical Teratoid/Rhabdoid Tumor</condition>
  <condition>Rhabdoid Tumor of the Kidney</condition>
  <arm_group>
    <arm_group_label>Ancillary-Correlative (gene expression profile, miRNA profile)</arm_group_label>
    <description>Archived tumor tissue samples are analyzed for gene expression profile and microRNA profile.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory Biomarker Analysis</intervention_name>
    <description>Correlative studies</description>
    <arm_group_label>Ancillary-Correlative (gene expression profile, miRNA profile)</arm_group_label>
  </intervention>
  <eligibility>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Samples of RTK and ATRT provided by the Children?s Oncology Group (COG)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simone Sredni</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Oncology Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Childrens Oncology Group</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>October 1, 2011</study_first_submitted>
  <study_first_submitted_qc>October 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2011</study_first_posted>
  <last_update_submitted>August 3, 2018</last_update_submitted>
  <last_update_submitted_qc>August 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhabdoid Tumor</mesh_term>
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

